Bioventus Inc.

Nasdaq:BVS

Surgical & Medical Instruments & Apparatus·DURHAM, NC

CEO

Claypoole Robert E

CFO

Singleton Mark Leonard

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/5/26	→
10-Q	Q3 2025	9/27/25	11/4/25	→
10-Q	Q2 2025	6/28/25	8/6/25	→
10-Q	Q1 2025	3/29/25	5/6/25	→
10-K	FY 2024	12/31/24	3/11/25	→
10-Q	Q3 2024	9/28/24	11/5/24	→
↓

Earnings Releases (8-K)

27 shown

Filed	Period
3/5/26	Q1 FY2026	→
11/4/25	Q4 FY2025	→
8/6/25	Q3 FY2025	→
5/6/25	Q2 FY2025	→
3/11/25	Q1 FY2025	→
11/5/24	Q4 FY2024	→
↓

News (8-K)

42 shown

Filed	Type	Description
11/17/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
8/4/25	Agreement	Entry into a Material Definitive Agreement	→
7/31/25	Other	Other Events	→
6/4/25	Vote	Submission of Matters to a Vote of Security Holders	→
1/3/25	Acquisition	Completion of Acquisition or Disposition of Assets	→
10/4/24	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

26 shown

Filed	Form	Description
3/5/26	S-8	S-8	→
4/22/25	ARS	ARS	→
3/11/25	S-8	S-8	→
11/4/24	424B3	424B3	→
10/25/24	S-3	S-3	→
4/26/24	ARS	ARS	→
↓

Filing History(427 filings)

TypeDateAccessionPeriodSize

S-8

Mar 5, 2026

0001665988-26-000012S-8

—

205.2 KB

10-K

Mar 5, 2026

0001665988-26-00001110-K

Dec 31, 2025

23.1 MB

8-K

Mar 5, 2026

0001665988-26-0000108-K

Mar 5, 2026

925.0 KB

Feb 18, 2026

0001914936-26-000002FORM 4

Feb 15, 2026

8.1 KB

Feb 18, 2026

0001204391-26-000002FORM 4

Feb 15, 2026

8.1 KB

Feb 18, 2026

0001835184-26-000003FORM 4

Feb 15, 2026

8.1 KB

SCHEDULE 13G/A

Feb 13, 2026

0001104659-26-015327

—

10.5 KB

Jan 13, 2026

0002005474-26-000002FORM 4

Jan 9, 2026

8.1 KB

Dec 8, 2025

0001198330-25-000003FORM 4

Dec 4, 2025

4.8 KB

144

Dec 4, 2025

0001959173-25-007511

—

4.7 KB

Nov 25, 2025

0002098243-25-000003FORM 3

Nov 14, 2025

372.1 KB

8-K

Nov 17, 2025

0001665988-25-0000328-K

Nov 14, 2025

177.5 KB

Nov 10, 2025

0001904156-25-000004FORM 4

Nov 7, 2025

4.9 KB

144

Nov 7, 2025

0001959173-25-006818

—

5.3 KB

10-Q

Nov 4, 2025

0001665988-25-00002610-Q

Sep 27, 2025

8.6 MB

8-K

Nov 4, 2025

0001665988-25-0000258-K

Nov 4, 2025

746.4 KB

SCHEDULE 13G/A

Aug 14, 2025

0001104659-25-078672

—

10.5 KB

10-Q

Aug 6, 2025

0001665988-25-00001710-Q

Jun 28, 2025

8.4 MB

8-K

Aug 6, 2025

0001665988-25-0000168-K

Aug 6, 2025

727.1 KB

8-K

Aug 4, 2025

0001193125-25-1721928-K

Jul 31, 2025

1.4 MB

8-K

Jul 31, 2025

0001665988-25-0000138-K

Jul 30, 2025

209.4 KB

Jun 10, 2025

0001578563-25-000316FORM 4

Jun 6, 2025

8.8 KB

Jun 5, 2025

0001578563-25-000312FORM 4

Jun 2, 2025

11.1 KB

Jun 4, 2025

0001578563-25-000310FORM 4

Jun 2, 2025

10.4 KB

Jun 4, 2025

0001578563-25-000309FORM 4

Jun 2, 2025

8.9 KB

25 filings shown

Bioventus Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(427 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/22/25	DEFA14A	DEFA14A	→
4/22/25	DEF 14A	DEF 14A	→
6/3/24	DEFA14A	DEFA14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/10/24	PRE 14A	PRE 14A	→
↓

Filed	Form	Description
2/18/26	4	4	→
2/18/26	4	4	→
2/18/26	4	4	→
1/13/26	4	4	→
12/8/25	4	4	→
11/25/25	3	FORM 3	→
↓

Filed	Form	Description
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/4/25	144	144	→
11/7/25	144	144	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
6/2/25	SD	SD	→
4/11/25	144	144	→
↓